UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
-----------------
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934*
PHARMION CORPORATION
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.001 PAR VALUE
--------------------------------------------------------------------------------
(Title of Class of Securities)
71715B409
--------------------------------------------------------------------------------
(CUSIP Number)
NOVEMBER 6, 2003
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[_] Rule 13d-1(b)
[_] Rule 13d-(c)
[X] Rule 13d-1(d)
----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
CELGENE CORPORATION
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
22-2711928
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER 1,939,598
SHARES
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER NONE
OWNED BY
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER 1,939,598
REPORTING
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER NONE
WITH
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH 1,939,598
REPORTING PERSON
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.1%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON (SEE INSTRUCTION) CO
ITEM 1(a). NAME OF ISSUER:
Pharmion Corporation
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
2528 28th Street, Boulder, Colorado 80301
ITEM 2(a). NAME OF PERSON FILING:
Celgene Corporation
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR IF NONE, RESIDENCE:
7 Powder Horn Drive, Warren, New Jersey 07059
ITEM 2(c). CITIZENSHIP:
Delaware
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock, $.001 par value
ITEM 2(e). CUSIP NUMBER:
71715B409
ITEM 3. Not applicable
ITEM 4(a). OWNERSHIP. AMOUNT BENEFICIALLY OWNED:
See Item 9 of the cover page attached hereto, which information is
hereby incorporated by reference.
ITEM 4(b). OWNERSHIP. PERCENT OF CLASS:
See Item 11 of the cover page attached hereto, which information is
hereby incorporated by reference.
ITEM 4(c). OWNERSHIP. NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
See Items 5 through 8 of the cover page attached hereto, which
information is hereby incorporated by reference.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not Applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not Applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
Not Applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not Applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
Not Applicable.
ITEM 10. CERTIFICATIONS.
Not Applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: March 8, 2004
CELGENE CORPORATION
By: /s/Robert J.Hugin
----------------------------------------
Name: Robert J.Hugin
Title: Chief Financial Officer